FundedIQ
Other

AviadoBio: Funding, Investors & Team (Sep 2026)

AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.

www.aviadobio.com LinkedIn London, United Kingdom 11-50 employees
Total raised
$77.9M
Rounds
2
Latest
Undisclosed round
Mar 2026

AviadoBio has raised $77.9M across 2 funding rounds on record, the most recent an undisclosed round announced in Mar 2026.

AviadoBio Company Profile and Key Stats

Total funding raised
$77.9M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Mar 2026
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Mar 2026.

AviadoBio Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Series A
$77.9M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

AviadoBio raised $77.9M in a Series A announced in Dec 2021.

4.3 years later, an undisclosed round was announced in Mar 2026 with no disclosed amount.

AviadoBio Founders and Leadership Team

Name
Role
Contact
Lisa Deschamps
CEO

No contact details are on record for this team yet.

AviadoBio Funding Compared to Other Other Startups

Segment
Companies
Median round
1,391
$3.0M
5,273
$4.0M

Funded Startups Like AviadoBio in Other and London

Companies Similar to AviadoBio

East Lothian Housing Association provides housing and helps in finding a new home, paying rent, and repairs…

Undisclosed round $11.3M

Ademen are revolutionising health pathways for humans and pets by giving expert health monitoring with SAAS…

Undisclosed round $2.1M

Defence Holdings is a defence technology company that develops and acquires software-based systems for…

Undisclosed round $5.3M

Pogust Goodhead is expanding its global alliance including over 100 lawyers and more than 500 staff…

Undisclosed round $150M

Astral Systems is a ground-breaking fusion technology that aims to tackle global health and energy…

Series A $30.4M

Acuity Group’s business is that of the supply of risk management services.

Undisclosed round $70k

Monument Technology offers a Banking Platform-as-a-Service designed for financial institutions seeking to…

Seed $23.9M

Record OS is an AI-powered accounting and tax platform built specifically to streamline the UK Self…

Pre-Seed $2.0M

Salboy is involved in the development process from beginning to end. They identify and assemble sites, design…

Undisclosed round $66.7M

The Conversion Flow is a digital marketing service focused on improving website performance and conversion…

Pre-Seed $150k

Apoha is a stealth stage start-up.

Undisclosed round $36.0M

Fretronics Engineering is an innovative electronic design, manufacturing, and repair company.

Undisclosed round $50k

AviadoBio Funding FAQs

What does AviadoBio do?

AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.

How much funding has AviadoBio raised?

AviadoBio has raised $77.9M across 2 rounds on record.

When did AviadoBio last raise funding?

AviadoBio's most recent funding round on record was announced in Mar 2026. The amount was not disclosed.

Who is the CEO of AviadoBio?

Lisa Deschamps is listed as CEO at AviadoBio.

Where is AviadoBio headquartered?

AviadoBio is based in London, England, United Kingdom.

How many employees does AviadoBio have?

AviadoBio is in the 11-50 employee band.

About FundedIQ's AviadoBio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AviadoBio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.